Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Enoby (denosumab-qbde), a Biosimilar to Prolia

Budapest, Hungary and London, UK, 29 September 2025 – Gedeon Richter Plc. (“Richter”) and Hikma Pharmaceuticals Plc. along with its wholly...

today New Drug Approvals

Evkeeza (evinacumab-dgnb) Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Evkeeza...

4 days ago New Drug Approvals

FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility

(BUSINESS WIRE)--Sep. 23, 2025-- Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives...

6 days ago New Drug Applications

Recently Added

Recently added consumer and prescribing information: Palsonify, Inluriyo, Forzinity, Enbumyst, Inlexzo, Nuvaxovid, mNEXSPIKE, Cyklx, Papzimeos, Brinsupri

For Consumers

For Professionals

For Researchers

Pharmaceutical Company Directory

Latest FDA New Drug Approvals

Enoby Enoby (denosumab-qbde) is a RANK ligand (RANKL) inhibitor biosimilar to Prolia (denosumab) used in the treatment of osteoporosis.
Bondlido Bondlido (lidocaine) is an amide local anesthetic topical system indicated in adults for relief of pain associated with post-herpetic neuralgia.
Palsonify Palsonify (paltusotine) is a somatostatin receptor agonist indicated for the treatment of adults with acromegaly who had an inadequate...

More FDA approvals

Drug Information

Tools

News & Alerts

Professionals

Top 100 Drugs

Recommended Content

Find Drugs & Conditions

FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)

FDA Approves Palsonify (paltusotine) for the Treatment of Acromegaly in Adults

FDA Approves Opzelura for Atopic Dermatitis in Children

FDA Approves Enoby (denosumab-qbde), a Biosimilar to Prolia

Evkeeza (evinacumab-dgnb) Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

FDA Approves Bondlido (lidocaine topical system) for the Treatment of Post-Herpetic Neuralgia

FDA Approves Palsonify (paltusotine) for the Treatment of Acromegaly in Adults

FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

AAP: Pediatric Golf Cart-Related Injuries Mainly Caused by Falls

Study Chronicles War-Related Injuries in Gaza

Self-Reported Cognitive Disability Rates Increased in U.S. Adults From 2013 to 2023

Adherence to ACS Guideline Linked to Lower Mortality in Nonmetastatic Prostate Cancer

Grocery Giant Recalls Deli Pastas Over Listeria Risk

Gen X Older Adults Show High Rates of Ultra-Processed Food Addiction

Millions of Corn Dogs Recalled Over Wooden Shards

Robot-Guided Device Reaches Tumors Deep In The Lungs